{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:50:34Z","timestamp":1780458634775,"version":"3.54.1"},"reference-count":56,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Follicular lymphoma (FL) is morphologically and clinically diverse, with mutations in epigenetic regulators alongside t(14;18) identified as disease-initiating events. Identification of additional mutational entities confirms this cancer\u2019s heterogeneity, but whether mutational data can be resolved into mechanistically distinct subsets remains an open question. Targeted sequencing was applied to an unselected population-based FL cohort (n\u00a0= 548) with full clinical follow-up (n\u00a0= 538), which included 96 diffuse large B-cell lymphoma (DLBCL) transformations. We investigated whether molecular subclusters of FL can be identified and whether mutational data provide predictive information relating to transformation. DNA extracted from FL samples was sequenced with a 293-gene panel representing genes frequently mutated in DLBCL and FL. Three clusters were resolved using mutational data alone, independent of translocation status: FL_aSHM, with high burden of aberrant somatic hypermutation (aSHM) targets; FL_STAT6, with high STAT6 &amp; CREBBP mutation and low aSHM; and FL_Com, with the absence of features of other subtypes and enriched KMT2D mutation. Analysis of mutation signatures demonstrated differential enrichment of predicted mutation signatures between subgroups and a dominant preference in the FL_aSHM subgroup for G(C&amp;gt;T)T and G(C&amp;gt;T)C transitions consistent with previously defined aSHM-like patterns. Of transformed cases with paired samples, 17 of 26 had evidence of branching evolution. Poorer overall survival (OS) in the aSHM group (P\u00a0= .04) was associated with older age; however, overall tumor genetics provided limited information to predict individual patient risk. Our approach identifies 3 molecular subclusters of FL linked to differences in underlying mechanistic pathways. These clusters, which may be further resolved by the inclusion of translocation status and wider mutation profiles, have implications for understanding pathogenesis as well as improving treatment strategies in the future.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005284","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T22:26:00Z","timestamp":1648851960000},"page":"5716-5731","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":33,"title":["Molecular subclusters of follicular lymphoma: a report from the United Kingdom\u2019s Haematological Malignancy Research Network"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-2859","authenticated-orcid":false,"given":"Simon","family":"Crouch","sequence":"first","affiliation":[{"name":"1Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3936-7569","authenticated-orcid":false,"given":"Daniel","family":"Painter","sequence":"additional","affiliation":[{"name":"1Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Barrans","sequence":"additional","affiliation":[{"name":"2Haematological Malignancy Diagnostic Service, St. James\u2019s Institute of Oncology, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7603-3704","authenticated-orcid":false,"given":"Eve","family":"Roman","sequence":"additional","affiliation":[{"name":"1Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Beer","sequence":"additional","affiliation":[{"name":"3Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna L.","family":"Cooke","sequence":"additional","affiliation":[{"name":"4Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Glover","sequence":"additional","affiliation":[{"name":"2Haematological Malignancy Diagnostic Service, St. James\u2019s Institute of Oncology, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan J.L.","family":"Van Hoppe","sequence":"additional","affiliation":[{"name":"2Haematological Malignancy Diagnostic Service, St. James\u2019s Institute of Oncology, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichola","family":"Webster","sequence":"additional","affiliation":[{"name":"2Haematological Malignancy Diagnostic Service, St. James\u2019s Institute of Oncology, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart E.","family":"Lacy","sequence":"additional","affiliation":[{"name":"1Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8395-2853","authenticated-orcid":false,"given":"Camilo","family":"Ruiz","sequence":"additional","affiliation":[{"name":"3Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Campbell","sequence":"additional","affiliation":[{"name":"3Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6225-2033","authenticated-orcid":false,"given":"Daniel J.","family":"Hodson","sequence":"additional","affiliation":[{"name":"7Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Patmore","sequence":"additional","affiliation":[{"name":"6Queen\u2019s Centre for Oncology and Haematology, Castle Hill Hospital, Cottingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Burton","sequence":"additional","affiliation":[{"name":"2Haematological Malignancy Diagnostic Service, St. James\u2019s Institute of Oncology, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1111-966X","authenticated-orcid":false,"given":"Alexandra","family":"Smith","sequence":"additional","affiliation":[{"name":"1Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2915-7119","authenticated-orcid":false,"given":"Reuben M.","family":"Tooze","sequence":"additional","affiliation":[{"name":"5Section of Experimental Haematology, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"issue":"3","key":"2023053013342003200_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2023053013342003200_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-2776(10)05007-8","article-title":"BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis","volume":"105","author":"Basso","year":"2010","journal-title":"Adv Immunol"},{"issue":"4706","key":"2023053013342003200_bib3","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"issue":"14","key":"2023053013342003200_bib4","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1073\/pnas.83.14.5214","article-title":"Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma","volume":"83","author":"Tsujimoto","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4720","key":"2023053013342003200_bib5","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.3929382","article-title":"The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining","volume":"229","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"issue":"1","key":"2023053013342003200_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0092-8674(86)90362-4","article-title":"Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2\/immunoglobulin transcript resulting from the t(14;18) translocation","volume":"47","author":"Cleary","year":"1986","journal-title":"Cell"},{"issue":"1","key":"2023053013342003200_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood.V79.1.229.229","article-title":"Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin\u2019s lymphomas","volume":"79","author":"Tanaka","year":"1992","journal-title":"Blood"},{"issue":"6844","key":"2023053013342003200_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"issue":"7","key":"2023053013342003200_bib9","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1073\/pnas.1120791109","article-title":"Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes","volume":"109","author":"Kato","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2023053013342003200_bib10","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","article-title":"Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma","volume":"121","author":"Green","year":"2013","journal-title":"Blood"},{"issue":"10","key":"2023053013342003200_bib11","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2023053013342003200_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"18","key":"2023053013342003200_bib13","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood-2013-04-496893","article-title":"EZH2 mutations are frequent and represent an early event in follicular lymphoma","volume":"122","author":"B\u00f6d\u00f6r","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2023053013342003200_bib14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","article-title":"Activating STAT6 mutations in follicular lymphoma","volume":"125","author":"Yildiz","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2023053013342003200_bib15","doi-asserted-by":"crossref","first-page":"e1002197","DOI":"10.1371\/journal.pmed.1002197","article-title":"Histological transformation and progression in follicular lymphoma: a clonal evolution study","volume":"13","author":"Kridel","year":"2016","journal-title":"PLoS Med"},{"issue":"10","key":"2023053013342003200_bib16","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood-2013-05-500264","article-title":"Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2023053013342003200_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"5","key":"2023053013342003200_bib18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"15","key":"2023053013342003200_bib19","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"2023053013342003200_bib20","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"issue":"4","key":"2023053013342003200_bib21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A\u00a0probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"2023053013342003200_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bjh.17132","article-title":"Application of the LymphGen classification tool to 928 clinically and genetically-characterised cases of diffuse large B cell lymphoma (DLBCL)","volume":"192","author":"Runge","year":"2021","journal-title":"Br J Haematol"},{"issue":"2","key":"2023053013342003200_bib23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/leu.2014.209","article-title":"Genomic and epigenomic co-evolution in follicular lymphomas","volume":"29","author":"Loeffler","year":"2015","journal-title":"Leukemia"},{"issue":"8","key":"2023053013342003200_bib24","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2016-05-717355","article-title":"Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy","volume":"128","author":"Jurinovic","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2023053013342003200_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjh.16159","article-title":"M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy","volume":"188","author":"Lockmer","year":"2020","journal-title":"Br J Haematol"},{"issue":"3","key":"2023053013342003200_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyy044","article-title":"Cohort profile: the Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort","volume":"47","author":"Smith","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"5","key":"2023053013342003200_bib27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2141.2009.08010.x","article-title":"The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research","volume":"148","author":"Smith","year":"2010","journal-title":"Br J Haematol"},{"key":"2023053013342003200_bib28","first-page":"dyab275","article-title":"Cohort profile update: the Haematological Malignancy Research Network (HMRN)\u2019s UK population-based cohorts","author":"Roman","year":"2022","journal-title":"Int. J. Epidemiol"},{"issue":"7","key":"2023053013342003200_bib29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s43018-020-0093-8","article-title":"Author correction: a practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies","volume":"1","author":"Degasperi","year":"2020","journal-title":"Nat Cancer"},{"key":"2023053013342003200_bib30","author":"StataCorp","year":"2019"},{"key":"2023053013342003200_bib31","author":"R Core Team. R","year":"2020"},{"issue":"8","key":"2023053013342003200_bib32","first-page":"1","article-title":"FlexMix: A General Framework for Finite Mixture Models and Latent Class Regression in R","volume":"11","author":"Leisch","year":"2004","journal-title":"J\u00a0Stat Softw"},{"key":"2023053013342003200_bib33","author":"Therneau","year":"2020"},{"issue":"7180","key":"2023053013342003200_bib34","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature06547","article-title":"Two levels of protection for the B cell genome during somatic hypermutation","volume":"451","author":"Liu","year":"2008","journal-title":"Nature"},{"issue":"3","key":"2023053013342003200_bib35","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3324\/haematol.2020.274258","article-title":"Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma","volume":"107","author":"Ma","year":"2022","journal-title":"Haematologica"},{"issue":"3","key":"2023053013342003200_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjh.15041","article-title":"The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion","volume":"180","author":"Zam\u00f2","year":"2018","journal-title":"Br J Haematol"},{"issue":"6","key":"2023053013342003200_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J"},{"issue":"6","key":"2023053013342003200_bib38","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.2016.51","article-title":"Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations","volume":"29","author":"Siddiqi","year":"2016","journal-title":"Mod Pathol"},{"issue":"22","key":"2023053013342003200_bib39","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"2023053013342003200_bib40","doi-asserted-by":"crossref","first-page":"e20200573","DOI":"10.1084\/jem.20200573","article-title":"Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas","volume":"218","author":"Ye","year":"2021","journal-title":"J\u00a0Exp Med"},{"issue":"11","key":"2023053013342003200_bib41","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1038\/s41375-019-0509-6","article-title":"Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes","volume":"33","author":"Alkodsi","year":"2019","journal-title":"Leukemia"},{"issue":"7","key":"2023053013342003200_bib42","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/s41375-021-01251-z","article-title":"Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas","volume":"35","author":"H\u00fcbschmann","year":"2021","journal-title":"Leukemia"},{"issue":"6","key":"2023053013342003200_bib43","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","article-title":"Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma","volume":"114","author":"Ritz","year":"2009","journal-title":"Blood"},{"issue":"23","key":"2023053013342003200_bib44","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","article-title":"Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study","volume":"33","author":"Casulo","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"2023053013342003200_bib45","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1172\/JCI63186","article-title":"Pathogenesis of follicular lymphoma","volume":"122","author":"Kridel","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"2023053013342003200_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ng.3473","article-title":"Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma","volume":"48","author":"Okosun","year":"2016","journal-title":"Nat Genet"},{"issue":"5","key":"2023053013342003200_bib47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccell.2020.03.016","article-title":"Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma","volume":"37","author":"Dheilly","year":"2020","journal-title":"Cancer Cell"},{"issue":"4","key":"2023053013342003200_bib48","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2016-07-729954","article-title":"Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma","volume":"129","author":"Krysiak","year":"2017","journal-title":"Blood"},{"issue":"11","key":"2023053013342003200_bib49","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood.2020010432","article-title":"SGK1 mutations in DLBCL generate hyperstable protein neoisoforms that promote AKT independence","volume":"138","author":"Gao","year":"2021","journal-title":"Blood"},{"issue":"7841","key":"2023053013342003200_bib50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-020-3017-y","article-title":"Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture","volume":"589","author":"Yusufova","year":"2021","journal-title":"Nature"},{"issue":"1","key":"2023053013342003200_bib51","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41467-020-20707-x","article-title":"Short H2A histone variants are expressed in cancer","volume":"12","author":"Chew","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"2023053013342003200_bib52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood-2018-07-865428","article-title":"Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016","volume":"133","author":"Qu","year":"2019","journal-title":"Blood"},{"issue":"13","key":"2023053013342003200_bib53","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1084\/jem.20151250","article-title":"The G protein-coupled receptor P2RY8 and follicular dendritic cells promote germinal center confinement of B cells, whereas S1PR3 can contribute to their dissemination","volume":"212","author":"Muppidi","year":"2015","journal-title":"J\u00a0Exp Med"},{"issue":"22","key":"2023053013342003200_bib54","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood-2015-07-659938","article-title":"GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in\u00a0vivo","volume":"127","author":"Healy","year":"2016","journal-title":"Blood"},{"issue":"19","key":"2023053013342003200_bib55","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1073\/pnas.1901258116","article-title":"Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses","volume":"116","author":"Wang","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2023053013342003200_bib56","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1038\/s41467-019-12494-x","article-title":"Genetic modification of primary human B cells to model high-grade lymphoma","volume":"10","author":"Caeser","year":"2019","journal-title":"Nat Commun"}],"updated-by":[{"DOI":"10.1182\/bloodadvances.2023010265","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000}}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/21\/5716\/2054222\/blooda_adv-2021-005284-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/21\/5716\/2054222\/blooda_adv-2021-005284-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:36:38Z","timestamp":1685453798000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/21\/5716\/484590\/Molecular-subclusters-of-follicular-lymphoma-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":56,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2022,11,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005284","relation":{"erratum":[{"id-type":"doi","id":"10.1182\/bloodadvances.2023010265","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]}}}